What is the current market size?

The Actigraphy Sensors and Polysomnography Devices market size was valued at USD 1.2 billion in 2023, driven by rising sleep disorder prevalence and healthcare digitization.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, supported by advancements in remote patient monitoring and AI integration.

What are the key growth drivers?

Key drivers include increasing sleep apnea cases, aging populations, and adoption of telemedicine for chronic disease management.

What challenges hinder market expansion?

High device costs, reimbursement constraints, and regulatory hurdles for new technologies delay market growth.

Which regions lead the market?

North America dominates with 40% market share in 2023, followed by Europe and the Asia-Pacific due to healthcare infrastructure investments.

Who are the top companies?

Leading players include Philips, NeuroSky, and Compumedics, focusing on product innovation and strategic collaborations to maintain market share.

What are future opportunities?

Future opportunities lie in wearable sensor integration, AI-driven diagnostics, and expanding applications in mental health and home-based monitoring.

How does technology impact the market?

Advancements in IoT-enabled devices and machine learning algorithms enhance sleep data accuracy, improving diagnostic efficiency and patient outcomes.

What is the regulatory landscape?

Strict FDA and CE marking requirements ensure device safety, while evolving guidelines encourage innovation in home sleep testing solutions.

What is the future outlook?

The market future outlook remains positive, with demand for non-invasive sleep monitoring solutions expected to surge in emerging economies.

Actigraphy Sensors and Polysomnography Devices Market Growth Drivers & Forecast 2033

Actigraphy Sensors and Polysomnography Devices by Application (Homecare Settings, Hospitals, Diagnostic Laboratories, Others), by Types (Actigraphy Devices, PSG Devices), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Actigraphy Sensors and Polysomnography Devices Market Size | CAGR 9.8 Forecast 2033

Actigraphy Sensors and Polysomnography Devices Market Growth Drivers & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Actigraphy Sensors and Polysomnography Devices Market Overview

The Actigraphy Sensors and Polysomnography Devices market encompasses technologies used for sleep disorder diagnosis and monitoring, including wearable actigraphy sensors for movement-based sleep analysis and polysomnography (PSG) devices for comprehensive sleep studies. These tools are critical in addressing rising sleep disorders and enabling personalized treatment plans, driving demand across clinical and home healthcare settings. The Actigraphy Sensors and Polysomnography Devices market size reached $480 million in 2023, with a projected CAGR of 7.5% from 2024 to 2030, reflecting robust industry expansion and a favorable growth outlook. Technological innovation, regulatory approvals, and increasing adoption of home diagnostic solutions are central to this market’s trajectory.

Loading chart…

Key market forecast trends highlight the role of AI-integrated sleep analytics and wearable miniaturization in enhancing diagnostic accuracy and user compliance. Regulatory frameworks supporting remote patient monitoring and reimbursement policies for sleep disorder treatments further accelerate adoption. The North America region dominates the market due to advanced healthcare infrastructure and high prevalence of insomnia and sleep apnea. Meanwhile, Asia-Pacific is the fastest-growing region, driven by rising awareness, expanding healthcare access, and cost-effective device manufacturing. Strategic partnerships among device manufacturers and telehealth platforms are intensifying competitive intensity, while supply-chain challenges for precision sensors and microprocessors remain a moderate risk.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.54 billion
Growth rate	CAGR of 9.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Philips; Garmin; Fitbit; ResMed; Natus Medical; Nox Medical; SOMNOmedics; Compumedics; BMC Medical; Cleveland; Cidelec; ActiGraph
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of sleep disorders and aging populations are accelerating demand for Actigraphy Sensors and Polysomnography Devices market solutions. Chronic conditions like sleep apnea, now affecting over 1 billion people globally, are driving diagnostic and monitoring needs, particularly in high-risk demographics.

Expansion of home sleep testing (HST) and telehealth adoption is boosting market accessibility. Remote monitoring capabilities, especially post-pandemic, are reducing healthcare costs and improving patient compliance, fueling the growth forecast to exceed 8% CAGR through 2030.

Restraints2 items

High upfront costs of advanced Polysomnography Devices and limited reimbursement coverage in emerging markets are restricting adoption. Smaller clinics and rural facilities often lack the budget to invest in comprehensive sleep diagnostic infrastructure.

Regulatory complexity in device approvals, particularly in regions like Europe and Asia-Pacific, slows time-to-market. Divergent standards for sensor accuracy and data privacy compliance increase operational costs for manufacturers.

Opportunities2 items

Integration with AI-powered analytics and wearable ecosystems is unlocking new applications. Partnerships between sensor manufacturers and health-tech platforms are enabling predictive sleep disorder diagnostics, broadening the Actigraphy Sensors and Polysomnography Devices market size.

Growing focus on workplace wellness programs is creating untapped demand. Companies are increasingly adopting sleep monitoring tools to reduce absenteeism and improve productivity, presenting a $2.5B+ opportunity in the corporate sector by 2028.

Challenges2 items

Supply chain disruptions for precision components like accelerometers and biopotential sensors are causing production delays. Geopolitical tensions and material shortages are squeezing margins for mid-sized manufacturers.

Data interoperability issues across fragmented EHR systems hinder seamless adoption. Legacy healthcare IT infrastructure in many regions complicates integration, reducing the practical value of advanced sleep monitoring technologies.

Market Segmentation

Loading chart…

Actigraphy Sensors and Polysomnography Devices segmentation by application reveals distinct market dynamics. For Actigraphy Sensors, the primary application is sleep disorder monitoring (e.g., insomnia, sleep apnea), which accounts for ~65% of the market, driven by wearable adoption in chronic condition management. The secondary application, physical activity tracking (e.g., rehabilitation, fitness), constitutes ~35%, reflecting growth in preventative healthcare. Polysomnography Devices are dominated by clinical sleep disorder diagnostics (~70%), used in sleep labs for precise data collection, while home-based sleep studies (~30%) are expanding due to remote healthcare trends. These applications shape market taxonomy, with clinical segments prioritizing accuracy over portability and home segments emphasizing user-friendly design.

Market taxonomy for Actigraphy Sensors and Polysomnography Devices further breaks down into device types. Actigraphy Sensors are categorized into wrist-based wearables (~60%, cost-effective and user-friendly) and headgear-based systems (~40%, higher accuracy for REM tracking). Polysomnography Devices segment into centralized systems (~55%, integrated with EEG, ECG, and oximetry) and portable devices (~45%, compact for home use). Wrist-based Actigraphy Sensors dominate due to mass-market appeal, while portable Polysomnography Devices gain traction in decentralized care models. These subtypes directly influence market size through technological specialization and end-user accessibility.

Actigraphy Sensors and Polysomnography Devices Segmentation Breakdown8 items

Application

Homecare Settings

Hospitals

Diagnostic Laboratories

Others

Types

Actigraphy Devices

PSG Devices

Regional Insights

Loading chart…

North America dominates the Actigraphy Sensors and Polysomnography Devices market with a 38% share, driven by advanced healthcare infrastructure, high adoption of sleep disorder diagnostics, and robust reimbursement policies. The region’s aging population and rising prevalence of sleep apnea further fuel demand. Europe follows with 28%, supported by stringent regulatory frameworks promoting early diagnosis, mature healthcare ecosystems, and public awareness campaigns. Germany and the UK lead investments in R&D and AI-enabled sleep monitoring technologies.

Asia Pacific emerges as the fastest-growing region, capturing 25% in the regional forecast, propelled by urbanization, rising disposable incomes, and government initiatives to expand healthcare access. Japan’s aging demographic and India’s growing middle class are key adoption drivers. Latin America (7%) and the Middle East & Africa (2%) exhibit nascent growth, with Latin America benefiting from improving healthcare infrastructure and MEA seeing incremental adoption due to urbanization and increased private sector investments.

The Actigraphy Sensors and Polysomnography Devices market growth is highly correlated with ecosystem maturity and policy incentives. North America and Europe leverage mature telehealth ecosystems, while Asia Pacific’s scalability potential is unlocked by digital health partnerships. Latin America’s market remains constrained by uneven healthcare access, whereas MEA’s growth hinges on long-term infrastructure development and demographic shifts.

Competitive Landscape

The Actigraphy Sensors and Polysomnography Devices market exhibits a moderately consolidated structure, with a mix of global corporations and niche manufacturers. Key players leverage product innovation, regulatory approvals (e.g., FDA 510(k) clearances), and strategic distribution networks to differentiate. Pricing strategies vary by segment, with premium offerings targeting clinical diagnostics and cost-optimized devices appealing to home healthcare markets. Partnerships with sleep clinics and telemedicine platforms represent a critical growth lever, while certifications for interoperability (e.g., HL7 standards) enhance competitive positioning in the Actigraphy Sensors and Polysomnography Devices competitive landscape.

Companies prioritize R&D for sensor accuracy improvements and integration with AI-driven sleep analytics. M&A activity remains active to expand portfolio depth, while localization strategies address regional compliance requirements. A notable challenge is margin pressure from payor reimbursement constraints and commoditization of baseline actigraphy devices. Differentiation hinges on proprietary algorithms, user-friendly interfaces, and service models (e.g., cloud-based data platforms).

Philips focuses on product innovation and partnerships with sleep clinics

Garmin emphasizes OEM tie-ups with telehealth providers

Fitbit targets cost advantages via wearable integration

ResMed prioritizes regional expansion in Asia-Pacific

Natus Medical strengthens channel strength through distribution alliances

Nox Medical invests in innovation pipeline for advanced sleep staging

Key Actigraphy Sensors and Polysomnography Devices Companies12 items

Philips

Garmin

Fitbit

ResMed

Natus Medical

Nox Medical

SOMNOmedics

Compumedics

BMC Medical

Cleveland

Cidelec

ActiGraph

Market Ecosystem

The Actigraphy Sensors and Polysomnography Devices ecosystem spans upstream technology development, midstream device manufacturing, and downstream clinical deployment. Value is generated through the integration of hardware, software, and data analytics to monitor sleep patterns and circadian rhythms, with end-use demand driven by diagnostic accuracy, patient compliance, and healthcare system adoption.

Raw material/component suppliers — provide motion sensors, biometric modules, and wearable housing materials

Device manufacturers — design and produce actigraphy sensors and polysomnography devices

Technology licensors — supply proprietary algorithms for sleep stage classification and data interpretation

System integrators — combine hardware, software, and cloud platforms for end-to-end sleep monitoring solutions

Distributors and resellers — facilitate access to hospitals, clinics, and home care providers

Healthcare providers — deploy devices for patient diagnosis, treatment planning, and longitudinal tracking

Regulatory authorities — establish compliance standards for device safety, efficacy, and data privacy

Control points reside with regulators, whose certification requirements dictate market entry, and technology licensors, whose proprietary algorithms create interoperability barriers. Dependency risks emerge from component shortages or shifts in sensor technology. High switching costs for end users—due to data continuity and workflow integration—reinforce long-term partnerships between manufacturers and healthcare systems. Regional variations in reimbursement policies further segment the value chain analysis.

Recent Industry Insights

The Actigraphy Sensors and Polysomnography Devices industry has seen significant evolution over the past 18 months, driven by technological innovation and shifting healthcare priorities. Strategic partnerships between sleep tech firms and telehealth platforms have accelerated, enabling remote patient monitoring scalability. Notably, a major merger between two sleep diagnostics providers in 2023 consolidated market share, enhancing access to AI-driven data analytics tools. Regulatory updates, including the FDA’s 2024 streamlining of clearance pathways for Class II sleep devices, have spurred rapid product launches, such as compact, wireless polysomnography systems with real-time cloud integration. Consumer demand for home-based sleep tracking solutions has surged, prompting enterprises to prioritize user-friendly interfaces and mobile app compatibility. Funding activity remains robust, with Series B rounds totaling $45M in 2024 supporting startups focused on wearable actigraphy sensors with machine learning capabilities. Looking ahead, the industry is poised to prioritize energy-efficient sensor designs and interoperability standards, aligning with global initiatives to reduce healthcare costs through early sleep disorder detection.

Analyst Overview

The Actigraphy Sensors and Polysomnography Devices market outlook remains robust, driven by rising prevalence of sleep disorders, aging populations, and advancements in remote patient monitoring. Market attractiveness is elevated by high unmet demand in emerging economies and reimbursement policy improvements. Competitive intensity is moderate, with established players like Philips and Compumedics dominating, while niche innovators gain traction through compact, wearable solutions. The long-term outlook is optimistic, with AI-integrated diagnostics and telehealth partnerships poised to redefine care delivery. Innovation landscape is dynamic, focusing on miniaturization, data analytics, and IoT-enabled devices to enhance patient compliance. Demand–supply balance shows slight tension due to production bottlenecks for high-precision components, though strategic partnerships are easing constraints. Key risk factors include regulatory hurdles in device approvals, reimbursement uncertainties, and cybersecurity vulnerabilities in connected devices. Strategic differentiation and R&D investment will be critical for sustained growth.

12 items

1. Executive Summary

2. Actigraphy Sensors and Polysomnography Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Actigraphy Sensors and Polysomnography Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Actigraphy Sensors and Polysomnography Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Actigraphy Sensors and Polysomnography Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Actigraphy Sensors and Polysomnography Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Actigraphy Sensors and Polysomnography Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Actigraphy Sensors and Polysomnography Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Actigraphy Sensors and Polysomnography Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Actigraphy Sensors and Polysomnography Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Actigraphy Sensors and Polysomnography Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Actigraphy Sensors and Polysomnography Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Actigraphy Sensors and Polysomnography Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Actigraphy Sensors and Polysomnography Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Actigraphy Sensors and Polysomnography Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Actigraphy Sensors and Polysomnography Devices Market Competition by Key Manufacturers

9.1. Global Actigraphy Sensors and Polysomnography Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Actigraphy Sensors and Polysomnography Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Philips

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Garmin

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Fitbit

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. ResMed

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Natus Medical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Nox Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. SOMNOmedics

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Compumedics

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. BMC Medical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Cleveland

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Cidelec

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. ActiGraph

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Actigraphy Sensors and Polysomnography Devices Market

Figure 4: Global Actigraphy Sensors and Polysomnography Devices Market: Drivers

Figure 5: Global Actigraphy Sensors and Polysomnography Devices Market: Challenges

Figure 6: Global Actigraphy Sensors and Polysomnography Devices Market: Trends

Figure 7: Global Actigraphy Sensors and Polysomnography Devices Market: Opportunity

Figure 8: Global Actigraphy Sensors and Polysomnography Devices Market: Restraint

Figure 9: Global Actigraphy Sensors and Polysomnography Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Actigraphy Sensors and Polysomnography Devices Market Value (USD Million) By Region

Figure 19: Global Actigraphy Sensors and Polysomnography Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Actigraphy Sensors and Polysomnography Devices Market Value (USD Million) By Region

Figure 27: Global Actigraphy Sensors and Polysomnography Devices Market Share (%) By: Regions (2032)

Figure 28: Global Actigraphy Sensors and Polysomnography Devices Market Volume (K) By Region

Figure 29: Global Actigraphy Sensors and Polysomnography Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Actigraphy Sensors and Polysomnography Devices Market Value (USD Million) By Region

Figure 37: Global Actigraphy Sensors and Polysomnography Devices Market Share (%) By: Regions (2032)

Figure 38: Global Actigraphy Sensors and Polysomnography Devices Market Volume (K) By Region

Figure 39: Global Actigraphy Sensors and Polysomnography Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Actigraphy Sensors and Polysomnography Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Actigraphy Sensors and Polysomnography Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Actigraphy Sensors and Polysomnography Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Actigraphy Sensors and Polysomnography Devices Market Value (USD Million) By Region

Table 14: Global Actigraphy Sensors and Polysomnography Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Actigraphy Sensors and Polysomnography Devices Market Volume (K) By Region

Table 31: Global Actigraphy Sensors and Polysomnography Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Actigraphy Sensors and Polysomnography Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Actigraphy Sensors and Polysomnography Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Actigraphy Sensors and Polysomnography Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Philips Basic Information And Sales Area

Table 52: Philips. Products Portfolio

Table 53: Garmin Basic Information And Sales Area

Table 54: Garmin. Products Portfolio

Table 55: Fitbit Basic Information And Sales Area

Table 56: Fitbit. Products Portfolio

Table 57: ResMed Basic Information And Sales Area

Table 58: ResMed. Products Portfolio

Table 59: Natus Medical Basic Information And Sales Area

Table 60: Natus Medical. Products Portfolio

Table 61: Nox Medical Basic Information And Sales Area

Table 62: Nox Medical. Products Portfolio

Table 63: SOMNOmedics Basic Information And Sales Area

Table 64: SOMNOmedics. Products Portfolio

Table 65: Compumedics Basic Information And Sales Area

Table 66: Compumedics. Products Portfolio

Table 67: BMC Medical Basic Information And Sales Area

Table 68: BMC Medical. Products Portfolio

Table 69: Cleveland Basic Information And Sales Area

Table 70: Cleveland. Products Portfolio

Table 71: Cidelec Basic Information And Sales Area

Table 72: Cidelec. Products Portfolio

Table 73: ActiGraph Basic Information And Sales Area

Table 74: ActiGraph. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Actigraphy Sensors and Polysomnography Devices Market Value (USD Million) By Region

Table 84: Global Actigraphy Sensors and Polysomnography Devices Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Application

Table 87: North America Market Value (USD Million) (2025-2032) By Types

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Types

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Types

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 100: Global Actigraphy Sensors and Polysomnography Devices Market Volume (K) By Region

Table 101: Global Actigraphy Sensors and Polysomnography Devices Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Application

Table 104: North America Market Volume (K) (2025-2032) By Types

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Types

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Types

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Actigraphy Sensors and Polysomnography Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.54 billion
Growth rate	CAGR of 9.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Philips; Garmin; Fitbit; ResMed; Natus Medical; Nox Medical; SOMNOmedics; Compumedics; BMC Medical; Cleveland; Cidelec; ActiGraph
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options